Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the population over the age of 60. Patients with the advanced forms of AMD have central scotomas (blind spots) in their field of vision. One of the challenges of low vision intervention is to help these patients use eccentric retina when their central retina is blind. One factor in using eccentric retina effectively may be remapping of the visual cortex. ? Until the early 1990s, it was widely believed that the anatomical structure of cortical tissue did not change once it was established following early development. However, evidence has now accumulated showing rapid and dramatic cortical plasticity in adulthood following the loss of sensory input due to peripheral lesions. For example, amputation of a limb first causes the cortex previously receiving input from that limb to be silent, but shortly thereafter, this region begins to respond to stimulation of adjacent regions of the skin. It is believed that changes in the efficacy of lateral connections within cortex are responsible for this phenomenon. In the visual system, there is some evidence from cellular recordings in animals with scotomas caused by laser treatment to the retina, and from filling-in phenomena in humans, that such remapping does occur, but its relationship to visual function has not been characterized. ? In the proposed project, we will investigate changes in the cortical mapping of retinal input using functional magnetic resonance imaging (fMRI) in humans with retinal lesions caused by geographic atrophy, the advanced atrophic form of age-related macular degeneration (AMD) and a model system for studying central scotomas in general. ? The specific aims of this proposal are (1) to determine the nature and extent of cortical remapping in patients with central scotomas from AMD using fMRI, following a detailed assessment of retinal function with a scanning laser ophthalmoscope, and (2) to determine whether and how cortical remapping contributes to the development of a stable eccentric preferred retinal locus in these patients. ? ?

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Research Grants (R03)
Project #
7R03EY014148-03
Application #
6858538
Study Section
Special Emphasis Panel (ZEY1-VSN (01))
Program Officer
Oberdorfer, Michael
Project Start
2003-04-01
Project End
2009-02-28
Budget Start
2005-09-01
Budget End
2009-02-28
Support Year
3
Fiscal Year
2005
Total Cost
$122,080
Indirect Cost
Name
Greater Baltimore Medical Center, Inc.
Department
Type
DUNS #
064874050
City
Baltimore
State
MD
Country
United States
Zip Code
21204
Bernstein, Aryeh; Sunness, Janet S; Applegate, Carol A et al. (2016) MAPPING THE DENSE SCOTOMA AND ITS ENLARGEMENT IN STARGARDT DISEASE. Retina 36:1741-50
Paker, A M; Sunness, J S; Brereton, N H et al. (2010) Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. Neurology 75:826-30
Sunness, Janet S; Schartz, R Brandon; Thompson, John T et al. (2009) Patterns of referral of retinal patients for low vision intervention in the anti-VEGF era. Retina 29:1036-9
Sunness, Janet S; Steiner, Joshua N (2008) Retinal function and loss of autofluorescence in stargardt disease. Retina 28:794-800
Sunness, Janet S; Rubin, Gary S; Broman, Aimee et al. (2008) Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology 115:1480-8, 1488.e1-2
Sunness, Janet S (2008) Face Fields and Microperimetry for Estimating the Location of Fixation in Eyes with Macular Disease. J Vis Impair Blind 102:679-689
Sunness, Janet S; Applegate, Carol A (2005) Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration. Am J Ophthalmol 140:1085-93
Sunness, Janet S; Liu, Taosheng; Yantis, Steven (2004) Retinotopic mapping of the visual cortex using functional magnetic resonance imaging in a patient with central scotomas from atrophic macular degeneration. Ophthalmology 111:1595-8